Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy.
about
Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle.Effect of L-carnitine on exercise performance in patients with mitochondrial myopathyFailed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis.Mitochondrial and inflammatory changes in sporadic inclusion body myositisThe ageing neuromuscular system and sarcopenia: a mitochondrial perspective.Mitochondrial DNA deletions in muscle satellite cells: implications for therapiesElevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscleMyopathology of Adult and Paediatric Mitochondrial Diseases.Heterozygous SSBP1 start loss mutation co-segregates with hearing loss and the m.1555A>G mtDNA variant in a large multigenerational family.3,3'-Diaminobenzidine staining interferes with PCR-based DNA analysis.Early-onset cataracts, spastic paraparesis, and ataxia caused by a novel mitochondrial tRNAGlu (MT-TE) gene mutation causing severe complex I deficiency: a clinical, molecular, and neuropathologic study.Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.A novel histochemistry assay to assess and quantify focal cytochrome c oxidase deficiency.Subcellular origin of mitochondrial DNA deletions in human skeletal muscle
P2860
Q35138773-FFAEC18A-861F-470D-A5D1-83A732C11B4DQ35565254-DC120F4D-02F8-4E42-8881-6D1154497622Q35928155-73E1A865-6481-4980-8C5B-772B83E1272EQ36164488-C2B43E52-CF0F-4AA1-9AE7-2EC0E6DBE547Q36802198-248AFA0A-C259-455C-8A33-E1E980D29CC0Q37172598-EB2F7766-7294-40CF-9CC7-0B4BC9F41F95Q37286993-C1F86DB1-004E-410D-958F-4A3DF9331A37Q37380152-328992CC-BC9B-42D7-BBC7-EE214C44857EQ39414816-731FCA99-7DC9-447C-A0C8-57D2D4A68E35Q47356323-73135A54-C374-4BF1-BF5C-228710A4071EQ47851087-75D16D25-659D-47AA-862B-473EB3DDF32FQ48201984-DF68F209-9161-47FC-BAC1-0D4168746CAFQ48285249-08C02E11-1836-4FEF-A222-72C690E6BB68Q52320281-AABA4824-7417-4128-A684-35EC2C403103Q57416781-40FD61C8-99F0-4599-BE41-3EF691DDDAA2
P2860
Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cytochrome c oxidase-intermedi ...... ent of mitochondrial myopathy.
@ast
Cytochrome c oxidase-intermedi ...... ent of mitochondrial myopathy.
@en
type
label
Cytochrome c oxidase-intermedi ...... ent of mitochondrial myopathy.
@ast
Cytochrome c oxidase-intermedi ...... ent of mitochondrial myopathy.
@en
prefLabel
Cytochrome c oxidase-intermedi ...... ent of mitochondrial myopathy.
@ast
Cytochrome c oxidase-intermedi ...... ent of mitochondrial myopathy.
@en
P2093
P2860
P1476
Cytochrome c oxidase-intermedi ...... ent of mitochondrial myopathy.
@en
P2093
Charlotte L Alston
Doug M Turnbull
Ersong Shang
Gavin Falkous
Julie L Murphy
Robert W Taylor
Ronald G Haller
Thiloka E Ratnaike
P2860
P304
P356
10.1016/J.NMD.2012.04.003
P577
2012-05-28T00:00:00Z